Yes, 2D echocardiography is the gold standard for diagnosing rheumatic heart disease (RHD).
Two-dimensional transthoracic echocardiography remains the cornerstone imaging modality for RHD diagnosis, with the 2023 World Heart Federation (WHF) guidelines providing the definitive diagnostic criteria 1, 2.
Diagnostic Framework
The 2023 WHF guidelines establish specific echocardiographic criteria for RHD diagnosis that include:
- Morphological features: Assessment of mitral and aortic valve thickening, restricted leaflet motion, and characteristic structural changes
- Pathological regurgitation: Defined criteria for mitral and aortic regurgitation that meet specific thresholds (Box 4 and Box 5 in the guidelines)
- Exclusion of other causes: Other valvular diseases (congenital heart disease, degenerative changes, bicuspid aortic valve) must be ruled out 1
Performance and Accuracy
2D echo has proven highly reliable for RHD detection. Clinical examination alone significantly underperforms compared to echocardiography—clinical evaluation can miss various lesions, especially when mild or when multiple lesions are present 3. The sensitivity and specificity of clinical examination varies widely by lesion type, whereas echocardiography provides consistent, objective assessment.
Practical Considerations
Standard vs. Handheld Devices
While standard 2D echocardiography is the reference standard, handheld echocardiography devices have demonstrated high diagnostic accuracy with pooled sensitivity of 0.87 and specificity of 0.98 for diagnosing RHD compared to standard echo (moderate certainty of evidence) 4. For screening purposes, handheld devices show sensitivity of 0.79 and specificity of 0.85 (high certainty of evidence) 4.
Important caveat: Handheld devices have limitations including:
- Minimal manual image optimization
- Low color scale capabilities
- Absence of spectral Doppler on many models
- These factors can impede full application of WHF 2023 criteria 1
Key Diagnostic Pitfalls
- Acute vs. chronic disease: Echocardiography cannot accurately determine when rheumatic changes occurred or reliably differentiate acute-on-chronic valvulitis from chronic RHD. Comparison with previous echocardiograms is necessary to assess progression 1
- Morphological changes: These often develop at later disease stages or might never appear, so they are not required for diagnosing acute carditis in acute rheumatic fever 1
- Multiple valve involvement: Mitral valve is most commonly affected, with isolated aortic involvement being rare. Mixed lesions occur more frequently than pure lesions 3
Clinical Application Algorithm
- Perform 2D echo with color Doppler in any patient with suspected RHD
- Apply WHF 2023 confirmatory criteria for valve morphology and pathological regurgitation
- Exclude other causes of valvular disease (congenital, degenerative)
- Compare with prior studies if available to assess progression
- Classify as: normal, borderline RHD, definite RHD, or other cardiac disease 1
Bottom line: Echocardiography should be routinely employed for management of patients with rheumatic fever or suspected rheumatic fever, as it is ideally suited to confirm and follow the course of RHD 5. Clinical examination alone is insufficient for accurate diagnosis 3.